Co-administration of cyclosporin enables oral therapy with paclitaxel
- 1 July 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 352 (9124) , 285
- https://doi.org/10.1016/s0140-6736(98)24030-x
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833British Journal of Cancer, 1997
- Genetic dissection of the function of mammalian P-glycoproteinsTrends in Genetics, 1997
- Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineProceedings of the National Academy of Sciences, 1997
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994